Product Name :
Human VEGF R2 Protein

EN
CD309; KDR; VEGFR; VEGFR2; VEGFR-21; FLK1; KRD1; Ly73

Description:
| Human VEGF R2/KDR Protein with the C-mFc Tag |Source: The reco|The reco|>95% by SEC-HPLC and SDS-|Less than 1 EU per ug of protein as determined by LAL method. |Formulation: Lyophilized from 0.22 um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization. |Reconstitution: It is recommended to reconstitute the lyophilized reco|The reco|The reco|>95% by SEC-HPLC and SDS-|Less than 1 EU per ug of protein as determined by LAL method. |Formulation: Lyophilized from 0.22 um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization. |Reconstitution: It is recommended to reconstitute the lyophilized reco|The recombinant Human VEGF R2/KDR Protein is shipped with ice |Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70°C as supplied. 1 week, 2 to 8°C under sterile conditions after reconstitution. 6 months, -20 to -70°C under sterile conditions after reconstitution.

Source:
The recombinant Human VEGF R2/KDR Protein, (amino acids Ala20-Glu764) fused with a mFc tag at the C-terminus, was produced in HEK 293 cells.

Molecular Weight :
The recombinant Human VEGF R2/KDR protein with the mFc tag at the C-terminus has a predicted MW of 110 kDa. Due to glycosylation, the protein migrates to 150-200 kDa based on Bis-Tris PAGE result.

Activity:
Immobilized recombinant Human VEGF165 protein with the C-mFc tag 1 ug/ml (100 ul/Well) on the plate. Dose response curve for the recombinant Human VEGF R2 protein with the C-mFc tag with the EC50 of 42.3 ng/ml determined by ELISA.

Purity :
>95% by SEC-HPLC and SDS-PAGE under reducing conditions.

Endotoxin:
LevelLess than 1 EU per ug of protein as determined by LAL method.

Formulation :
Lyophilized from 0.22 um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization.

Reconstitution:
It is recommended to reconstitute the lyophilized recombinant Human VEGF R2/KDR Protein in sterile H2O to a protein concentration not less than 100 ug/ml. Centrifuge the tube before opening. BP005397Human VEGF R2/KDR Protein with the C-His-Avi Tag SourceThe recombinant Human VEGF R2/KDR Protein, (amino acids Ala20-Glu764) fused with a His-Avi tag at the C-terminus, was produced in HEK 293 cells.

Shipping:
The recombinant Human VEGF R2/KDR Protein is shipped with ice pack. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage :
/strong>Use a manual defrost freezer and avoid repeated freeze-thaw cycles.

MedChemExpress (MCE) recombinant proteins include: cytokines, enzymes, growth factors, hormones, receptors, transcription factors, antibody fragments, etc. They are often essential for supporting cell growth, stimulating cell signaling pathways, triggering or inhibiting cell differentiation; and are useful tools for elucidating protein structure and function, understanding disease onset and progression, and validating pharmaceutical targets. At MedChemExpress (MCE), we strive to provide products with only the highest quality. Protein identity, purity and biological activity are assured by our robust quality control and assurance procedures.
Related category websites: https://www.medchemexpress.com/recombinant-proteins.html
Popular product recommendations:
CD105/Endoglin Proteincustom synthesis
FAM20B ProteinGene ID
Popular categories:
Breast Tumor Kinase
Complement C1q A-Chain (C1QA)